Citation: A. Wimo et al., ECONOMIC-IMPACT OF INTRODUCING PROPENTOFYLLINE FOR THE TREATMENT OF DEMENTIA IN SWEDEN, Clinical therapeutics, 20(3), 1998, pp. 552-566
Citation: A. Wimo et al., TREATMENT OF ALZHEIMER-DISEASE WITH TACRINE - A COST-ANALYSIS MODEL, Alzheimer disease and associated disorders, 11(4), 1997, pp. 191-200
Authors:
WINBLAD B
HILL S
BEERMANN B
POST SG
WIMO A
Citation: B. Winblad et al., ISSUES IN THE ECONOMIC-EVALUATION OF TREATMENT FOR DEMENTIA - POSITION PAPER FROM THE INTERNATIONAL WORKING GROUP ON HARMONIZATION OF DEMENTIA DRUG GUIDELINES, Alzheimer disease and associated disorders, 11, 1997, pp. 39-45
Citation: B. Winblad et al., WHAT ARE THE COSTS TO SOCIETY AND TO INDIVIDUALS REGARDING DIAGNOSTICPROCEDURES AND CARE OF PATIENTS WITH DEMENTIA, Acta neurologica Scandinavica, 94, 1996, pp. 101-104
Citation: A. Wimo et al., CARE FOR DEMENTED PATIENTS IN DIFFERENT LIVING-CONDITIONS, Scandinavian journal of primary health care, 13(3), 1995, pp. 205-210
Authors:
WIMO A
MATTSON B
KRAKAU I
ERIKSSON T
NELVIG A
KARLSSON G
Citation: A. Wimo et al., COST-UTILITY ANALYSIS OF GROUP LIVING IN DEMENTIA CARE, International journal of technology assessment in health care, 11(1), 1995, pp. 49-65
Citation: A. Wimo et al., THE IMPACT OF COGNITIVE DECLINE AND WORKLOAD ON THE COSTS OF DEMENTIACARE, International journal of geriatric psychiatry, 9(6), 1994, pp. 479-489
Citation: A. Wimo et al., ASSESSMENTS OF PRODUCTIVITY OF PSYCHOGERIATRIC DAY-CARE, International journal of geriatric psychiatry, 8(8), 1993, pp. 675-679